Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

190 projects found matching your search criteria :

  1. Disorders of indispensable metals homeostasis and changes in levels of toxic metals in alternative materials in patients...

    Call: PRELUDIUM 2 , Panel: NZ7

    Principal investigator: dr Anna Maria Woźniak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  2. Design, synthesis and biological evaluation of methylthio analogues of combretastatin A-4 - potential antimitotic agents

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: prof. Stanisław Kazimierz Sobiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  3. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Piktel

    Uniwersytet Medyczny w Białymstoku

  4. New Horizons in Cancer Immunotherapy: Blocking LAG-3/FGL1 Interactions

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Jacek Plewka

    Uniwersytet Jagielloński

  5. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  6. Analysis of the effects of proteotoxic stress on cholesterol homeostasis and its associations with cardiovascular diseas...

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Wiesława Elżbieta Widłak

    Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy

  7. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

  8. Biomaterial enriched with propolis extract as a promising chemopreventive dressing material after melanoma excision

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Marta Trzaskowska

    Uniwersytet Medyczny w Lublinie

  9. Small molecule modulators of the tumor necrosis factor alpha signaling pathway for the inhibition of inflammatory proces...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Tadeusz Holak

    Uniwersytet Gdański

  10. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    Uniwersytet Śląski w Katowicach

  11. Controlling the covalent activity of a PD-L1 inhibitors with light

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktor Jan Uzar

    Uniwersytet Jagielloński

  12. Design, synthesis and biological evaluation of Steroid Sulfatase Inhibitors based on organophosphorus compounds.

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Sebastian Demkowicz

    Politechnika Gdańska

  13. CAR(dio)-T(oxicity)- Engineered Heart Tissue model for CAR-T cardiotoxicity evaluation

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Agnieszka Joanna Zimna

    Instytut Genetyki Człowieka Polskiej Akademii Nauk

  14. In search for DNA methylation aberrations associated with susceptibility to ovarian cancer

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr Malwina Magdalena Suszyńska

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  15. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  16. Mucoadhesive nanospheres as an intravesical form of monomethyl auristatin E

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk

  17. Integrated multi-omics approach to accelerate anticancer drug discovery by targeting metabolic reprogramming in human co...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Danuta Dudzik

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  18. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  19. Advanced statistical and deep learning models to predict cancer risk and support treatment decisions

    Call: SONATA BIS 13 , Panel: NZ2

    Principal investigator: dr Michał Marczyk

    Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

  20. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  21. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  22. Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  23. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to ...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marika Anna Frańczak

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  24. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen...

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: prof. Ryszard Józef Ostaszewski

    Instytut Chemii Organicznej Polskiej Akademii Nauk

  25. Are bisphenol S and F safe substitutes for bisphenol A in the face of environmental contamination with estrogenic mycoto...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Justyna Kozieł

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  26. The effect of PKC epsilon modification on autophagy in cancer cells.

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: prof. Maria Jolenta Rybczyńska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  27. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Łukasz Kuryk

    Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy

  28. Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Janusz Zbigniew Szemraj

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  29. Precise molecular characterization of circulating tumour cells in patients with triple negative breast cancer using high...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Stefano Volinia

    Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

  30. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  31. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Urszula Helena Piotrowska

    Warszawski Uniwersytet Medyczny

  32. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Rafał Artur Bartoszewski

    Uniwersytet Wrocławski, Wydział Biotechnologii

  33. High-throughput PET imaging by decoding multi-photon signals on long axial field-of-view PET using physics-guided artifi...

    Call: OPUS 24 (LAP) , Panel: NZ7

    Principal investigator: prof. Ewa Łucja Stępień

    Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  34. A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven dis...

    Call: OPUS 24 (LAP) , Panel: NZ7

    Principal investigator: dr hab. Anna Karolina Więckowska

    Uniwersytet Jagielloński, Collegium Medicum

  35. A smart stride for cancer: synergistic effect of co-delivery chemo- andphototherapeutic agents using magneto-fluorescent...

    Call: POLONEZ BIS 2 , Panel: NZ7

    Principal investigator: dr Prachi Uttam Ghoderao

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  36. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  37. Bionanoparticles with a molecular targeting device as a weapon for breast cancer

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  38. Allosteric and allosteric-orthosteric bitopic ligands of histamine receptor H4 as a way to increase selectivity and bias...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Sławomir Hubert Filipek

    Uniwersytet Warszawski, Wydział Chemii

  39. ECbiome genotyping and assessment of its involvement in pathogenic processes of endometrial cancer development

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Aleksandra Maria Kowalczyk

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  40. Electrospun nanofiber-based nanoplatform for delivery of new nutraceutical derivatives to eliminate chemotherapy-induced...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr hab. Maciej Antoni Wnuk

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  41. Biomedical and chemometric assessment of the new analytical platform in the study of endogenous substances as potential ...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Lucyna Konieczna

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  42. Impact of the CDK4/6 targeted degradation by PROTACs on immune checkpoint signaling in cancer

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: dr Katarzyna Magiera-Mularz

    Uniwersytet Jagielloński, Wydział Chemii

  43. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  44. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  45. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap...

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  46. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami...

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

  47. New synthetic resveratrol derivatives with potential anti-ageing and anti-cancer properties

    Call: PRELUDIUM 2 , Panel: NZ7

    Principal investigator: dr Justyna Mikuła-Pietrasik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  48. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  49. Identification of breast cancer cells death and senescence mechanisms induction resulting from telomerase silencing with...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr hab. Błażej Rubiś

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  50. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Natalia Anna Maciejewska

    Politechnika Gdańska

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy